Literature DB >> 27260164

Relation between Carcinoembryonic Antigen Levels in Colon Cancer Tissue and Serum Carcinoembryonic Antigen Levels at Initial Surgery and Recurrence.

Gota Saito1, Sotaro Sadahiro, Kazutake Okada, Akira Tanaka, Toshiyuki Suzuki, Akemi Kamijo.   

Abstract

OBJECTIVES: Carcinoembryonic antigen (CEA) is widely used for postoperative surveillance of colon cancer. Even if serum CEA is negative at initial surgery, it may turn positive at recurrence. We investigated the relation between serum CEA levels and the immunohistochemical staining status of CEA in the primary and resected metastatic tissues.
METHODS: Out of 224 patients with recurrent colon cancer between 1998 and 2012, we studied 46 patients in whom serum CEA levels were measured and immunohistochemical staining for CEA was possible in the primary and metastatic tissues.
RESULTS: The positive rate of serum CEA did not differ between initial surgery and recurrence, regardless of whether the cutoff value was set at 5 or 10 ng/ml (p = 0.829, p = 0.671). There was no relation between the CEA staining status and serum CEA level at initial surgery. However, the CEA staining status of metastatic tissue was significantly related to the serum CEA level at recurrence (p = 0.0046 and p = 0.0026).
CONCLUSIONS: The immunohistochemical staining status of CEA in metastatic tissue is closely related to the serum CEA level. This finding suggests that serum CEA levels are influenced not only by the CEA production capacity of cancer cells but also by the ability of the surrounding tissue to release CEA into the blood.
© 2016 The Author(s) Published by S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27260164     DOI: 10.1159/000447062

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  7 in total

1.  Monitoring of Serum Carcinoembryonic Antigen Levels after Curative Resection of Colon Cancer: Cutoff Values Determined according to Preoperative Levels Enhance the Diagnostic Accuracy for Recurrence.

Authors:  Gota Saito; Sotaro Sadahiro; Hiroko Kamata; Hiroshi Miyakita; Kazutake Okada; Akira Tanaka; Toshiyuki Suzuki
Journal:  Oncology       Date:  2017-02-09       Impact factor: 2.935

2.  Comprehensive functional genomic analyses link APC somatic mutation and mRNA-miRNA networks to the clinical outcome of stage-III colorectal cancer patients.

Authors:  Sum-Fu Chiang; Heng-Hsuan Huang; Wen-Sy Tsai; Bertrand Chin-Ming Tan; Chia-Yu Yang; Po-Jung Huang; Ian Yi-Feng Chang; Jiarong Lin; Pei-Shan Lu; En Chin; Yu-Hao Liu; Jau-Song Yu; Jy-Ming Chiang; Hsin-Yuan Hung; Jeng-Fu You; Hsuan Liu
Journal:  Biomed J       Date:  2021-03-16       Impact factor: 7.892

3.  An Eight-CpG-based Methylation Classifier for Preoperative Discriminating Early and Advanced-Late Stage of Colorectal Cancer.

Authors:  Ji Hu; Fu-Ying Zhao; Bin Huang; Jing Ran; Mei-Yuan Chen; Hai-Lin Liu; You-Song Deng; Xia Zhao; Xiao-Fan Han
Journal:  Front Genet       Date:  2021-01-13       Impact factor: 4.599

4.  Incidence of Mortality and Associated Factors Among Colorectal Cancer Patients at Oncology Units of Northwest Ethiopia: A Retrospective Cohort Study.

Authors:  Yenework Mulu Tiruneh; Debrework Tesgera Beshah; Mulugeta Wassie
Journal:  Cancer Manag Res       Date:  2022-04-13       Impact factor: 3.602

5.  Relationship between Parameters Linked to Surgery, Hospitalization and Single Nucleotide Polymorphism in Patients with Colorectal Cancer.

Authors:  A Chirca; E Radu; D G Minca; R Costea
Journal:  Maedica (Bucur)       Date:  2018-09

6.  Selection of optimal molecular targets for tumor-specific imaging in pancreatic ductal adenocarcinoma.

Authors:  Willemieke S Tummers; Arantza Farina-Sarasqueta; Martin C Boonstra; Hendrica A Prevoo; Cornelis F Sier; Jan S Mieog; Johannes Morreau; Casper H van Eijck; Peter J Kuppen; Cornelis J van de Velde; Bert A Bonsing; Alexander L Vahrmeijer; Rutger-Jan Swijnenburg
Journal:  Oncotarget       Date:  2017-05-26

7.  In-Depth Mapping of the Urinary N-Glycoproteome: Distinct Signatures of ccRCC-related Progression.

Authors:  Lucia Santorelli; Giulia Capitoli; Clizia Chinello; Isabella Piga; Francesca Clerici; Vanna Denti; Andrew Smith; Angelica Grasso; Francesca Raimondo; Marco Grasso; Fulvio Magni
Journal:  Cancers (Basel)       Date:  2020-01-18       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.